Summary
The function of the inhibitory neurotransmitter, γ-aminobutyric acid (GABA), has been implicated in the mode of action of many drugs which excite or depress the central nervous system. Many convulsant agents appear to block GABA action whereas anticonvulsants enhance GABA action. Some of these drug effects involve altered GABA-mediated synaptic transmission at the level of GABA biosynthesis, release from nerve endings, uptake into cells, and metabolic degradation. A greater number of agents of diverse classes appear to affect GABA action at the postsynaptic membrane, as determined from both electrophysiological and biochemical studies. The recently developedin vitro radioactive receptor binding assays have led to a wealth of new information about GABA action and its alteration by drugs. GABA inhibitory transmission involves the regulation, by GABA binding to its receptor site, of chloride ion channels. In this GABA receptor-ionophore system, other drug receptor sites, one for benzodiazepines and one for barbiturates/picrotoxinin (and related agents) appear to form a multicomponent complex. In this complex, the drugs binding to any of the three receptor categories are visualized to have an effect on GABA-associated chloride channel regulation. Available evidence suggests that the complex mediates many of the actions of numerous excitatory and depressant drugs showing a variety of pharmacological effects.
Similar content being viewed by others
References
Meldrum, B., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.), pp. 390–405, Munksgaard, Copenhagen.
Olsen, R. W., Ticku, M. K., Greenlee, D. & Van Ness, P., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.), pp. 165–178, Munksgaard, Copenhagen.
Enna, S. J. & Snyder, S. H., 1975. Brain Res. 100: 81–97.
Nistri, A., Constanti, A. & Krnjević, K., 1980. In: Receptors for Neurotransmitters and Peptide Hormones (Pepeu, G., Kuhar, M. J. & Enna, S. J., eds.), Adv. Biochem. Psychopharmacol. Vol. 21, pp. 81–90, Raven Press, New York.
Curtis, D. R., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 17–27, Munksgaard, Copenhagen.
McBurney, R. N. & Barker, J. L., 1978. Nature 274: 596–597.
Zukin, S. R., Young, A. B. & Snyder, S. H., 1974. Proc. Natl. Acad. Sci. USA 71: 4802–4807.
Greenlee, D. V., Van Ness, P. C. & Olsen, R. W., 1978. Life Sci. 22: 1653–1662.
Napias, C., Bergman, M. O., Van Ness, P. C., Greenlee, D. V. & Olsen, R. W., 1980. Life Sci. 27: 1001–1011.
Coyle, J. T. & Enna, S. J., 1976. Brain Res. 111: 119–133.
Olsen, R. W., Greenlee, D., Van Ness, P. & Ticku, M. K., 1978. In: Amino Acids as Chemical Transmitters (Fonnum, F., ed.), pp. 467–486, Plenum Press, New York.
Olsen, R. W. & Mikoshiba, K., 1978. J. Neurochem. 30: 1633–1636.
Greenlee, D. V., Van Ness, P. C. & Olsen, R. W., 1978. J. Neurochem. 31: 933–938.
Enna, S. J., Ferkany, J. W. & Krogsgaard-Larsen, P., 1979. In GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 191–200, Munksgaard, Copenhagen.
Krogsgaard-Larsen, P., Hjeds, H., Curtis, D. R., Lodge, D. & Johnston, G. A. R., 1979. J. Neurochem. 32: 1717–1724.
Tallman, J. F., Paul, S. M., Skolnick, P. & Gallager, D. W., 1980. Science 207: 274–281.
Squires, R. F. & Braestrup, C., 1977. Nature 266: 732–734.
Möhler, H. & Okada, T., 1977. Science 198, 849–851.
Costa, T., Rodbard, D. & Pert, C. B., 1979. Nature 277: 315–317.
Haefely, W., Polc, P., Schaffner, R., Keller, H. H., Pieri, L. & Möhler, H., 1979. GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. and Kofod, H., eds.) pp. 357–375, Munksgaard, Copenhagen.
Johnston, G. A. R., 1978. Ann. Rev. Pharmacol. Toxicol. 18: 269–289.
Olsen, R. W., Ticku, M. K., Van Ness, P. C. & Greenlee, D., 1978. Brain Res. 139, 277–294.
Olsen, R. W., Ticku, M. K. & Miller, T., 1978. Mol. Pharmacol. 14, 381–390.
Ticku, M. K. Ban, M. and Olsen, R. W., 1978. Mol. Pharmacol. 14: 391–402.
Ticku, M. K., Van Ness, P. C. Haycock, J. W., Levy, W. B. & Olsen, R. W., 1978. Brain Res 150: 642–647.
Leeb-Lundberg, F. & Olsen, R. W., 1980. In: Psychopharmacology and Biochemistry of Neurotransmitter Receptors (Yamamura, H. L, Olsen, R. W. & Usdin, E., eds.) pp. 593–606, Elsevier, New York.
Leeb-Lundberg, F., Napias, C. & Olsen, R. W., 1981. Brain Res., in the press.
Ticku, M. K. & Olsen, R. W., 1978. Life Sci. 22: 1643–1651.
Olsen, R. W., Leeb-Lundberg, F. & Napias, C., 1980. Brain Res. Bull. 5, Suppl. 2: 217–221.
Placheta, P. & Karobath, M., 1980. Eur. J. Pharmacol. 62: 225–228.
Olsen, R. W., Snowman, A. & Leeb-Lundberg, F., 1981. Fed. Proc. Abstracts, in press.
Johnston, G. A. R. & Willow, M., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 191–198, Raven Press, New York.
Beer, B., Klepner, C. A., Lippa A. S. & Squires, R. F., 1978. Pharmacol. Biochem. Behav. 9: 849–851.
Williams, M. & Risley, E. A., 1979. Life Sci. 24: 833–841.
O'Brien, R. A. & Spirt, N. M., 1980. Life Sci. 26: 1441–1445.
Leeb-Lundberg, F., Snowman, A. & Olson, R. W., 1980. Proc. Natl. Acad. Sci. USA, 77: 7468–7472.
Skolnick, P., Paul, S. & Barker, J. L., 1980. Eur. J. Pharmacol. 65, 125–127.
Sieghart, W., Placheta, P., Supavilai, P. & Karobath, M., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 121–128, Raven Press, New York.
Olsen, R. W. & Leeb-Lundberg, F., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G. eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 93–102, Raven Press, New York.
Supavilai, P. & Karobath, M., 1979. Eur. J. Pharmacol. 60, 111–113.
Tower, D. B., 1976. In: GABA in Nervous System Function (Roberts, E., Chase, T. N. & Tower, D. B., eds.) pp. 461–478, Raven Press, New York.
Horton, R. W., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 605–608.
Ribak, C. E., Harris, A. B., Vaughn, J. E. & Roberts, E., 1979. Science 205, 211–214.
Barker, J. L., Nicoll, R. A. & Padjen, A., 1975. J. Physiol. 245: 521–548.
Macdonald, R. L. & Barker, J. L., 1978. Neurology (Minneapolis) 28: 325–330.
Straughan, D. W., 1974. Neuropharmacol. 13: 495–508.
Schlosser, W. & Franco, S., 1979. J. Pharmacol. Exp. Ther. 211: 290–295.
Geller, H. M., 1979. Neurosci. Lett. 15: 313–318.
Bowery, N. G., Collins, J. F. & Hill, R. G., 1976. Nature 261: 601–603.
Dray, A., 1975. Neuropharmacol. 14: 703–705.
Simmonds, M. A., 1980. Neuropharmacol. 19: 39–45.
Goldstein, D. B., 1973. J. Pharmacol. Exp. Thera. 168: 1–9.
Cooper, B. R., Viik, K., Ferris, R., & White, H. L., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 815–820.
Straughan, D. W., 1978. Adv. Pharmacol. Thera. 2: 19–27.
Dray, A. & Bowery, N. G., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 376–389, Raven Press, New York.
Enna, S. J. & Maggi, A., 1979. Life Sci. 24: 1727–1738.
Bartholini, G., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 487–490.
Lippa, A. S., Klepner, C. A., Benson, D. I., Critchett, D. J., Sano M. C. & Beer, B., 1980. Br. Res. Bull. 5 Suppl. 2, pp. 861–866.
Haefely, W. E., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 873–878.
Macdonald, R. L. & Barker, J. L., 1979. Brain Res. 167: 323–326.
Loscher, W. & Frey, H. H., 1979. Naunyn. Schmiedebergs Arch. Pharmacol. 296: 263–269.
Metcalf, B. W., 1979. Biochem. Pharmacol. 28: 1705–1712.
Enna, S. J., Maggi, A., Worms, P. & Lloyd, K. G., 1980. Muscimol: Br. Res. Bull. 5, Suppl. 2, pp. 461–464.
Krogsgaard-Larsen, P., 1980. Mol. Cell. Biochem. 31: 105–121.
Meldrum, B., Pedley, T., Horton, R., Anlezark, G. & Franks, A., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 685–690.
Frey, H.-H., Popp, C. & Loscher, W., 1979. Neuropharmacology 18: 581–590.
Fariello R, G, & Golden G. T., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 691–700.
Krogsgaard-Larsen, P., Johnston, G. A. R., Lodge, D. & Curtis, D. R., 1977. Nature 268, 53–54.
Meldrum, B. & Horton, R., 1980. Eur. J. Pharmacol 61: 231–237.
Frey, H.-H. & Loscher, W., 1980. Neuropharmacol. 19: 217–220.
Morselli, P. L., Bossi, L., Henry, J. F., Zarifian, E. & Bartholini, G., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 411–424.
Nicoll, R. A. & Wojtowicz, J. M., 1980. Brain Res. 191: 225–237.
Hochner, B., Spira, M. E. & Werman, R., 1976. Brain Res. 107: 85–103.
Dingledine, R. & Gjerstad, L., 1979. Brain Res. 168: 205–209.
Macdonald, R. L. & Barker, J. L., 1977. Nature 267: 720–721.
Nicoll, R. A. & Padjen, A., 1976. Neuropharmacol. 15: 69–71.
Scholfield, C. N., 1979. Br. J. Pharmacol. 67: 443P-444P.
Pellmar, T. C. & Wilson, W. A., 1977. Science 197: 912–913.
Downes, H. & Williams, J. K., 1969. J. Pharmacol. Exp. Thera. 168: 283–289.
Nestoros, J. N., 1980. Science 209: 708–710.
Macdonald, R. L. & Bergey, G. K., 1979. Brain Res. 170: 558–562.
Hayashi, T. & Negishi, K., 1979. Brain. Res. 175: 271–278.
Geller, H. M., Abstr. Soc. Neurosci. 6: 538 (1980) #184.5.
Raabe, W. & Ayala, G. F., 1976. Brain Res. 105: 597–601.
Ayala, G. F., Lin, S. & Johnston, D., 1977. Brain Res. 121: 245–258.
Deisz, R. A. & Lux, H. D., 1977. Neurosci. Lett. 5, 199–203.
Hershkowitz, N. & Ayala, G. F., 1980. Soc. Neurosci. Abstr. 6, 183 (#64.6).
Naik, S. R., Naid, P. R. & Sheth, U. K., 1978. Psychopharmacol. 57: 103–107.
Davidoff, R. A., J. c. Hackman & V. Grayson. Br. Res. Bull, 5, Suppl. 2, pp. 665–672.
Barker, J. L. & McBurney, R. N., 1979. Proc. R. Soc. Lond. 206: 319–327.
Ransom, B. R. & Barker, J. L., 1976. Brain Res. 114: 530–535.
Evans, R. H., 1979. Brain Res. 171: 113–120.
Schlosser, W. & Franco, S., 1980. Neuropharmacol. 18: 377–381.
Tsuchiya, T. & Fukushima, H., 1978. Eur. J. Pharmacol 48: 421–424.
Brown, D. A. & Constanti, A., 1978. Br. J. Pharmacol. 63: 217–224.
Curtis, D. R. & Lodge, D., 1977. Nature 270: 543–544.
Lebeda, F. J., Brown, T. H. & Johnston, D., 1980. Soc. Neurosci. Abstr. 6, 183 (#64.8).
Nicoll, R. A., Eccles, J. C., Oshima, T. C. & Rubia, F., 1975. Nature 258: 625–627.
Bowery, N. G. & Dray, A., 1978. Br. J. Pharmacol. 63: 179–215.
Richards, C. D., 1972. J. Physiol. 227: 749–767.
Fink, B. R. (ed.), 1980. Molecular Mechanisms of Anesthesia, Progress in Anesthesiology, Vol. 2, Raven Press, New York.
Collins, G. G., 1980. Brain Res. 290: 517–528.
Potashner, S. J., Lake, N., Langlois, E. A., Plouffe, L. & Lecavalier, D., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 659–665.
Costa, E. & Guidotti, A., 1979. Ann. Rev. Pharmacol. Toxicol. 19: 531–545.
Sepinwall, J. & Cook, L., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 839–848.
Waddington, J. L., 1978. Eur. J. Pharmacol. 51: 417–422.
Schmidt, R. F., Vogel, M. E., Zimmermann, M., 1967. Naunyn-Schmiedebergs Archives Pharmacol. 258: 69–82.
Dray, A. & Straughan, D. W., 1976. J. Pharm. Pharmacol. 28: 314–315.
Curtis, D. R., Lodge, D., Johnston, G. A. R. & Brand, S. J., 1976. Brain Res. 118: 344–347.
Raabe, W. & Gumnit, R. J., 1977. Epilepsia 18: 117–120.
Nistri, A. & Constanti, A., 1978. Neuropharmacol. 17: 127–135.
Simmonds, M. A., 1980. Nature 284: 558–560.
Polzin, R. L. & Barness, C. D., 1979. Neuropharmacol. 18: 431–434.
Okamoto, K. & Sakai Y., 1979. Br. J. Pharmacol. 65: 277–285.
Gallager, D. W., 1978. For. J. Pharmacol, 49: 133–143.
Zakusov, V. V., Ostrovskaya, R. U., Kozhechkin, S. N., Markovich, V. V., Molodavkin, G. M. & Voronina, T. A., 1977. Arch. Int. Pharmacodyn. Ther. 229: 313–326.
Geller, H. M., Hoffer, B. J. & Taylor, D. A., 1980. Fed. Proc. 39: 3016–3023.
Montarolo, P. G., Raschi, F. & Strata, P., 1979. Brain Res. 162: 358–362.
Macdonald, R. & Barker, J. L., 1978. Nature 271: 563–564.
Choi, D. W., Farb, D. H. & Fischbach, G. D., 1979. Nature 269: 342–344.
Olsen, R. W., Bergman, M. O., Van Ness, P. C., Lummis, S. C., Watkins, A. E., Napias, C. & Greenlee, D. V., 1981. Mol. Pharmacol. in the press.
Olsen, R. W., 1981. In: Psychopharmacology and Biochemistry of Neurotransmitter Receptors (Yamamura, H. I., Olsen, R. W. & Usdin, E., eds.) pp. 537–550, Elsevier, New York.
Lloyd, K. G. & Dreksler, S., 1978. In: Amino Acids as Chemical Transmitters (Fonnum, F., ed.) pp. 457–466, Plenum Press, New York.
Olsen, R. W., Van Ness, P. C., Napias, C., Bergman, M. & Tourtellotte, W. W., 1980. In: Receptors for Neurotransmitters and Peptide Hormones (Pepeu, G., Kuhar, M. J. & Enna, S. J., eds.) Adv. Biochem. Psychopharmacol. Vol. 21, pp. 451–460, Raven Press, New York.
Simantov, R., Oster-Granite, M. L., Herndon, R. M. & Snyder, S. H., 1976. Brain Res. 105, 365–371.
Campochiaro, R., Schwarcz, R. & Coyle, J. T., 1977. Brain Res. 136, 501–511.
Biggio, G., Corda, M. G., De Montis, G., Stefanini, E. & Gessa, G. L., 1980. Brain Res 193: 589–593.
Waddington, J. L. & Cross, A. J., 1980. Br. Res. Bull. 5, Suppl. 2, 825–828.
Guidotti, A., Gale, K., Suria, A. & Toffano, G., 1979. Brain Res. 172: 566–571.
Enna, S. J., Bennett, J. P., Bylund, D. B., Snyder, S. H., Bird, E. D. & Iversen, L. L., 1976. Brain Res. 116, 531–537.
Olsen, R. W., Reisine, T. D. & Yamamura, H. I., 1980. Life Sci. 27, 801–808.
Beaumont, K., Chilton, W., Yamamura, H. I. & Enna, S. J., 1978. Brain Res. 148: 153–162.
Morin, A. M. & Wasterlain, C., 1980. Life Sci. 26: 1239–1245.
Krogsgaard-Larsen, P., Snowman, A., Lummis, S. C. & Olsen, R. W., 1981. J. Neurochem, in the press.
Mohler, H. & Okada, T., 1977. Nature 267: 65–67.
Enna, S. J. & Snyder, S. H., 1977. Mol. Pharmacol. 13: 442–453.
Wong, D. T., Bymaster, F. P. & Lane, P. T., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 853–856.
Toffano, G., Guidotti, A. & Costa, E., 1978. Proc. Natl. Acad. Sci. USA 75, 4024–4028.
Johnston, G. A. R. & Kennedy, S. M. E., 1978. In: Amino Acids as Chemical Transmitters (Fonnum, F., ed.) pp. 507–516, Plenum Press, New York.
Yoneda, Y. & Kuriyama, K., 1980. Nature 285: 670–673.
Young, A. B. & Snyder, S. H., 1974. Proc. Nat. Acad. Sci. USA 71: 4002–4005.
Goldinger, A. & Müller, W. E., 1980. Neurosci. Lett 16: 91–95.
Takeuchi, A. & Takeuchi, N., 1969. J. Physiol. 205: 377–391.
Ticku, M. K. & Olsen, R. W., 1977. Biochim. Biophys. Acta 464: 519–529.
Ticku, M. K. & Olsen, R. W., 1979. Neuropharmacol. 18: 315–318.
Leeb-Lundberg, F., Snowman, A. & Olsen, R. W., 1981. Fed. Proc. Abstracts, in the press.
Randall, L. O., Schallek, W., Sternbach, L. H. & Ning, R. Y., 1974. In: Psychopharmacology Agents III (Gordon, M., ed) pp. 175–281, Academic Press, New York.
Paul, S. M., Syapin, P. J., Paugh, B. A., Moncada, A. & Skolnick, P., 1979. Nature 281: 688–689.
Mazière, M., Godot, J. M., Berger, G., Baron, J. C., Comar, D., Cepeda, C., Menini, C. & Nauquet, R., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. in Biochem. Psychopharmacol. Vol. 26, pp. 273–286, Raven Press, New York.
Duka, T., Hollt, V. & Herz, A., 1979. Brain Res. 179: 147–156.
Young, W. S. & Kuhar, M. J., 1979. Nature 280, 393–395.
Shibuya, H., Gale, K. & Pert, C. B., 1980. Eur. J. Pharmacol. 62: 243–244.
Chang, R. S., Tran, V. T. & Snyder, S. H., 1980. Brain Res. 190: 95–110.
Biggio, G., Corda, M. G., Lamberti, C. & Gessa, G. L., 1979. Eur. J. Pharmacol. 58: 215–216.
Möhler, H., Okada, T. & Enna, S.J., 1978. Brain Res. 156: 391–395.
Gallager, D. W., Thomas, J. W. & Tallman, J. F., 1978. Biochem. Pharmacol. 27: 2745–2749.
Gallager, D. W., Mallorga, P. & Tallman, J. F., 1980. Brain Res. 180: 209–220.
Speth, R. C., Bresolin, N., Mimaki, T., Deshmukh, P. P. & Yamamura, H. I., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. in Biochem. Psychopharmacol. Vol. 26, pp. 27–39, Raven Press, New York.
Paul, S. M. & Skolnick, P., 1978. Science 202: 892–894.
McNamara, J. O., Peper, A. M. & Patrone, V., 1980. Proc. Natl. Acad. Sci. USA 77: 3029–3032.
Nestoros, J. N., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 849–852.
Möhler, H., Battersby, M. K. & Richards, J. G., 1980. Proc. Natl. Acad. Sci. USA 77: 1666–1670.
Placheta, P. & Karobath, M., 1979. Brain Res. 178: 580–583.
Wastek, G. J., Speth, R. C., Reisine, T. D. & Yamamura, H. I., 1978. Eur. J. Pharmacol. 50: 445–447.
Sieghart, W. & Karobath, M., 1980. Nature 286, 285–287.
Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J. Klepner, C. A., Myers, V. & Beer, B., 1979. Pharmacol. Biochem. Behav. 10: 825–830.
Marangos, P. J., Paul, S. M., Parma, A. M., Goodwin, F. K., Syapin, P. & Skolnick, P., 1979. Life Sci. 24: 851–858.
Snyder, S. H. & Childers, S. R., 1979. Ann. Rev. Neurosci. 2: 35–64.
Asano, T. & Spector, S., 1979. Proc. Natl. Acad. Sci. USA 76: 977–981.
Davies, L. P., Cook, A. F., Poonian, M. & Taylor, K. M., 1980. Life Sci. 26: 1089–1095.
Möhler, H., Polc, P., Cumin, R., Pieri, L. & Kettler, R., 1979. Nature 278: 563–565.
Olsen, R. W. & Leeb-Lundberg, F., 1980. Eur. J. Pharmacol. 65: 101–104.
Braestrup, C., Nielsen, M. & Olsen, C. E., 1980. Proc. Natl. Acad. Sci. USA 77: 2288–2292.
Davis, L. G. & Cohen, R. K., 1980. Biochem. Biophys. Res. Comm. 92: 141–148.
Araki, T., Ito, M. & Oscarsson, O., 1961. J. Physiol. 159: 410–435.
Martin, I. L. & Candy, J. M., 1980. Neuropharmacol. 19: 175–179.
Tallman, J. F., Thomas, J. W. & Gallager, D. W., 1978. Nature 274: 383–385.
Karobath, M. & Sperk, G., 1979. Proc. Natl. Acad. Sci. USA 76: 1004–1006.
Briley, M. S. & Langer, S. Z., 1978. Eur. J. Pharmacol. 52: 129–132.
Chiu, T. H. & Rosenberg, H. C., 1979. Eur. J. Pharmacol. 56: 337–345.
Dudai, Y., 1979. Brain Res. 167: 422–425.
Squires, R. F., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 129–138, Raven Press, New York.
Maurer, R., 1979. Neurosci. Lett. 12: 65–68.
Karobath, M., Placheta, P., Lippitsch, M. & Krogsgaard-Larsen, P., 1979. Nature 278: 748–749.
Braestrup, C., Nielsen, M., Krogsgaard-Larsen, P. & Falch, E., 1979. Nature 280: 331–333.
Karobath, M. & Lippitsch, M., 1979. Eur. J. Pharmacol. 58: 485–488.
Barker, J. L. & Mathers, D. A., 1980. Soc. Neurosci. Abstr. 6, 189 (#67.2).
Supavilai, P. & Karobath, M., 1980. Neurosci. Lett. 19: 337–341.
Guidotti, A., Toffano, G., Baraldi, M., Schwartz, J. P. & Costa, E., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 406–415, Munksgaard, Copenhagen.
Massotti, M., Guidotti, A. & Costa, E., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 19–26, Raven Press, New York.
Meiners, B. A. & Salama, A. I., 1980. Soc. Neurosci. Abstr. 6, 189 (#467.4).
Gavish, M. & Snyder, S. H., 1980. Nature 287: 651–652.
Gavish, M. & Snyder, S. H., 1980. Life Sci. 26: 579–582.
Sherman-Gold, R. & Dudai, Y., 1980. Brain Res. 198: 485–490.
Fong, J. & Goldstein, M., 1980. Soc. Neurosci. Abstr. 6, 255 (#94.13).
Asano, T. & Ogasawara, N., 1980. Life Sci. 26: 607–613.
Asano, T. & Ogasawara, N., 1980. Life Sci. 26: 1131–1137.
Gavish, M. & Snyder, S. H., 1980. Soc. Neurosci. Abstr. 6, 236 (#89.2).
Yousufi, M. A. K., Thomas, J. W. & Tallman, J. F., 1979. Life Sci. 25: 463–470.
Lang, B., Barnard, E. A., Chang, L. R. & Dolly, J. O., 1979. FEBS Lett. 104: 149–153.
Bymaster, F. P. & Wong, D. T., 1980. Soc. Neurosci. Abstr. 6, 252 (#94.3).
Chiu, T. H. & Rosenberg, H. C., 1980. Fed. Proc. 39, 1006 (Abstr. #3889).
Greenlee, D. V. & Olsen, R. W., 1979. Biochem. Biophys, Res. Comm. 88: 380–387.
Butler, T. C., 1942. J. Pharmacol. 74: 118–128.
Burch, T. & Ticku, M. K., 1980. Eur. J. Pharmacol. 67: 325–326.
Huang, L.-Y. and Barker, J. L., 1980. Science 207: 195–197.
Supavilai, P. & Karobath, M., 1980. Ent. J. Pharmacol. 62: 229–233.
Karobath, M., Drexler, G. & Supavilai, P., 1981. Life Sci. 28: 307–313.
Waddington, J. L. & Cross, A. J., 1980. Br. Res. Bull. 5, Suppl. 2: 503–505.
Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J. & Turnbull, M., 1980. Nature 283: 92–94.
Skolnick, P., Syapin, P. J., Paugh, B. A., Moncada, V., Marangos, P. J. & Paul, S. M., (1979) Proc. Natl. Acad. Sci. USA 76: 1515–1518.
Ticku, M. K., 1980. Brain Res. Bull. 5: 919–923.
Tenen, S. S. & Hirsch, J. D., 1980. Nature 288, 609–610.
Ticku, M. K. & Burch, T., 1980. Biochem. Pharmacol. 29: 1217–1220.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olsen, R.W. The GABA postsynaptic membrane receptor-ionophore complex. Mol Cell Biochem 39, 261–279 (1981). https://doi.org/10.1007/BF00232579
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00232579